Smarter cancer care
Exact Sciences delivers the promise and value of precision medicine with the Oncotype IQ portfolio of genomic tests.

Landmark RxPONDER Trial Results

Presented at the 2020 SABCS

Exact Sciences' Response to COVID-19

A Letter from our CEO, Kevin Conroy

Making cancer care smarter.®
X

This site uses cookies. These cookies collect information about how visitors use a website, for instance which pages visitors go to most often, and if they get error messages from web pages. These cookies don’t collect information that identifies a visitor. All information these cookies collect is used only to improve the website. By visiting this website, you agree that we can place these types of cookies on your device.